LONDON--(BUSINESS WIRE)--Dec 1, 2019--
Technavio has been monitoring the global transfection reagents and equipment market and the market is poised to grow by USD 319.58 million during 2020-2024 at a CAGR of over 6% during the forecast period. Request Free Sample Pages
This press release features multimedia. View the full release here: www.businesswire.com/news/home/20191201005102/en/
Technavio has announced its latest market research report titled global transfection reagents and equipment market 2020-2024. (Graphic: Business Wire)
Read the 148-page research report with TOC on "Transfection Reagents and Equipment Market Analysis Report by Geography (Asia, Europe, North America, and ROW), by Product (Reagents and Equipment), and Segment Forecasts, 2020-2024".
The market is driven by the rising demand for timely disease diagnosis. In addition, the rise in clinical trials in developing nations is anticipated to further boost the growth of the transfection reagents and equipment market.
Early diagnosis diseases is necessary among patients with a high risk of hereditary conditions. It requires genetic tools to facilitate diagnostic tests such as next-generation sequencing and DNA microarrays. This is driving the demand for transfection reagents as they are used for conducting genetic variation testing procedures. They help in identifying risks of developing diseases such as Alzheimer’s disease, Parkinson’s disease, and cancer. Thus, the rising demand for timely disease diagnosis is expected to drive market growth during the forecast period.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
Major Five Transfection Reagents and Equipment Market Companies:
Agilent Technologies Inc.
Agilent Technologies Inc. is headquartered in the US and operates the business under various segments such as Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The company offers GeneJammer Transfection Reagent, a polyamine reagent to various end-users.
Bio-Rad Laboratories Inc.
Bio-Rad Laboratories Inc. is headquartered in the US and offers products through the following business units: Life Science and Clinical Diagnostics. The company offers Gene Pulser Xcell Electroporation System, which is a pulse generating system.
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. is headquartered in Switzerland and operates under the business segments, Pharmaceuticals and Diagnostics. The company offers X-tremeGENE DNA Transfection Reagent for the use of academic and research institutes and pharmaceutical and biotechnology companies.
Lonza Group Ltd.
Lonza Group Ltd. is headquartered in Switzerland and offers products through the following business segments: Pharma & Biotech and Specialty ingredients. The company offers a high-throughput transfection system, 4D-Nucleofector System, for the use of biotechnology and pharmaceutical companies.
MaxCyte Inc. is headquartered in the US and offers products through the business segment, Healthcare. The company offers a scalable transfection system, MaxCyte STX for the use of academic and research institutes and biotechnology and pharmaceutical companies.
Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio's SUBSCRIPTION platform
Transfection Reagents and Equipment Product Outlook (Revenue, USD Million, 2020-2024)
Transfection Reagents and Equipment Regional Outlook (Revenue, USD Million, 2020-2024)
- North America
Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more.Request a free sample report
Related Reports on Health Careinclude:
Hematology Analyzers and Reagents Market – Global Hematology Analyzers and Reagents Market by end-users (hospitals and diagnostic centers, blood bank centers, and others) and geography (Asia, Europe, North America, and ROW).
Biotechnology Reagents Market – Global Biotechnology Reagents Market by technology (chromatography, in-vitro diagnostics, polymerase chain reaction, cell culture, and others) and geography (the Americas, APAC, and EMEA).
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
CONTACT: Technavio Research
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
INDUSTRY KEYWORD: MEDICAL SUPPLIES HEALTH MEDICAL DEVICES INFECTIOUS DISEASES OTHER HEALTH CLINICAL TRIALS PHARMACEUTICAL
SOURCE: Technavio Research
Copyright Business Wire 2019.
PUB: 12/01/2019 09:30 PM/DISC: 12/01/2019 09:30 PM